Patheon Announces Board Change


    TORONTO, June 20 /CNW/ - Patheon Inc. announced today that George L.
Ploder has resigned as a director of Patheon.
    "We thank George for 15 years of dedicated service as a director of
Patheon," said Peter Green, Chairman of the Board of Directors.
    The Board is engaged in the process of identifying a suitable replacement
director and Audit Committee Chairman.


    Patheon (TSX:PTI; is a leading global provider of drug
development and manufacturing services to the international pharmaceutical
industry. Patheon operates a network of 14 facilities in the United States,
Canada and Europe, employing more than 5,200 people and serving a client base
of 250 pharmaceutical and biotechnology companies.

    %SEDAR: 00001700E

For further information:

For further information: Mr. Riccardo Trecroce, Chief Executive Officer,
Tel: (905) 812-6877, Fax: (905) 812-6613, Email:; Mr.
John Bell, Chief Financial Officer, Tel: (905) 812-6812, Fax: (905) 812-6613,
Email:; Ms. Shelley Jourard, Director, Corporate
Communications, Tel: (905) 812-6614, Fax: (905) 812-6613; Email:

Organization Profile

Patheon Inc

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890